BioLineRx to Report Third Quarter 2024 Results on November 25, 2024

Management to Hold Conference Call at 8:30 a.m. ESTTEL AVIV, Israel, Nov. 20, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its unaudited financial results for the third quarter ended September 30, 2024 on Monday, November 25, 2024, before the U.S. markets open.The Company will host a conference call at 8:30 a.m. EST featuring remarks by Philip ...